Grant opportunity preview
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Offered by National Institutes of Health
HealthcareNationalNovember 5, 2027
Opportunity summary
The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progre…
Sign in to review full eligibility requirements, application details, matching insights, and verified source links.